COMP <GO>
FCN vs EXPO // ENTERPRISE SCALE & MARKET CAP
FTI Consulting Inc. (NYSE) VS. Exponent Inc. (NASDAQ) • 15-METRIC TALLY: FCN 4
— EXPO 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: FCN
LAST: $191.77 (+4.88%) • MKT CAP: $4.98B
market-cap
$4.98B
LAST: $86.58 (+7.87%) • MKT CAP: $3.82B
market-cap
$3.82B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FCN VS. EXPO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FCN | EXPO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | 28.60% | -11.80 | EXPO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.6x | 28.7x | -17.10 | FCN | /valuation <GO> |
| Free Cash Flow Yield | 1.87% | 3.29% | -1.42 | EXPO | /fcf-yield <GO> |
| Operating Margin | 10.30% | 20.60% | -10.30 | EXPO | /operating-margins <GO> |
| Net Profit Margin | 7.10% | 18.20% | -11.10 | EXPO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.40% | 4.20% | -1.80 | EXPO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.65% | -1.65 | EXPO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.10 | 8.62 | -4.52 | EXPO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | EXPO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.1 | 72.3 | +6.80 | FCN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | EXPO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.2x | 32.6x | -15.40 | FCN | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.98B | $3.82B | $1.17B | FCN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FCN REV | EXPO REV | FCN GROSS % | EXPO GROSS % | FCN FCF | EXPO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.79B | $582.0M | 32.1% | — | $93.6M | $122.3M |
| FY 2024 | $3.70B | $558.5M | 32.0% | — | $359.7M | $137.6M |
| FY 2023 | $3.49B | $536.8M | — | — | $67.4M | $103.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FCN // BETA 0.87
EXPO // BETA 0.94